| Literature DB >> 33146205 |
Lu Tong1, Qunfei Zhao1, Emmanuel Datan2, Guo-Qiang Lin3, Il Minn4, Martin G Pomper4, Biao Yu5, Daniel Romo6, Qing-Li He1, Jun O Liu2.
Abstract
Covering: 2000 to 2020 Triptolide is a bioactive diterpene triepoxide isolated from Tripterygium wilfordii Hook F, a traditional Chinese medicinal plant whose extracts have been used as anti-inflammatory and immunosuppressive remedies for centuries. Although triptolide and its analogs exhibit potent bioactivities against various cancers, and inflammatory and autoimmune diseases, none of them has been approved to be used in the clinic. This review highlights advances in material sourcing, molecular mechanisms, clinical progress and new drug design strategies for triptolide over the past two decades, along with some prospects for the future course of development of triptolide.Entities:
Year: 2021 PMID: 33146205 DOI: 10.1039/d0np00054j
Source DB: PubMed Journal: Nat Prod Rep ISSN: 0265-0568 Impact factor: 13.423